Financial Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook byJosh SandbergJanuary 12, 2017
Extremities Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today byJosh SandbergAugust 1, 2016
Financial Integra LifeSciences Reports Second Quarter 2016 Financial Results byJosh SandbergJuly 29, 2016
Recon Integra LifeSciences launches Integra® Fin-Lock™ Glenoid for the Titan™ Modular Shoulder System byJosh SandbergMay 25, 2016
Hospitals Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release byJosh SandbergMay 12, 2016
Hospitals Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch byJosh SandbergApril 28, 2016
Financial Integra LifeSciences Reports First Quarter 2016 Financial Results byJosh SandbergApril 28, 2016
Extremities Integra LifeSciences Announces Initial Clinical Use of the Cadence™ Total Ankle System in the United States byJosh SandbergApril 27, 2016
Top Stories Integra LifeSciences Announces Agreement with Vomaris Wound Care, Inc. to Commercialize VolTAC™ Antimicrobial Wound Dressing byJosh SandbergApril 15, 2016
Extremities Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) byJosh SandbergJanuary 7, 2016
